Monte Rosa Therapeutics Inc (GLUE) — Financial Flexibility Index
Monte Rosa Therapeutics Inc (GLUE) has a Financial Flexibility Index of -0.17x as of March 2026. Free cash flow of $-35.50 Million (operating CF $-37.37 Million minus capex $1.87 Million) represents 0% of total liabilities ($214.51 Million). Also explore how fast is Monte Rosa Therapeutics Inc growing its equity to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Monte Rosa Therapeutics Inc Financial Flexibility Index (2019–2025)
Historical Financial Flexibility Index trend for Monte Rosa Therapeutics Inc across 7 annual periods. Check Monte Rosa Therapeutics Inc strategic capital allocation to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Monte Rosa Therapeutics Inc (2019–2025)
Year-by-year free cash flow to debt coverage for Monte Rosa Therapeutics Inc. For the full company profile including market capitalisation, see Monte Rosa Therapeutics Inc market cap and net worth.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.08x | $-18.10 Million | $-22.80 Million | $215.60 Million | ▼ -139.4% |
| 2024 | 0.21x | $45.98 Million | $42.00 Million | $215.80 Million | ▲ +207.1% |
| 2023 | -0.20x | $-24.76 Million | $-43.80 Million | $124.50 Million | ▲ +82.3% |
| 2022 | -1.12x | $-79.56 Million | $-92.47 Million | $70.98 Million | ▲ +57.5% |
| 2021 | -2.64x | $-49.63 Million | $-59.36 Million | $18.81 Million | ▼ -1216.1% |
| 2020 | -0.20x | $-19.66 Million | $-23.05 Million | $98.11 Million | ▲ +2.7% |
| 2019 | -0.21x | $-4.79 Million | $-6.17 Million | $23.24 Million | — |